Metformin for the Prevention of Oral Cancer in Patients With Oral Leukoplakia or Erythroplakia
Metformin for the Prevention of Oral Cancer in Patients With Oral Leukoplakia or Erythroplakia
Active, not recruiting · NCT05237960 · Registry updated 2026-09-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Metformin for the Prevention of Oral Cancer in Patients With Oral Leukoplakia or Erythroplakia | Erythroplasia, Head and Neck Neoplasms, Mouth Neoplasms, Neoplasms by Site, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Stomatognathic Diseases, erythroplakia, leukoplakia, mouth disorder, neoplasm, oral mucosa leukoplakia, precancerous condition | Active, not recruiting | Phase 2 | 2026-09-28 | NCT05237960 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Cancer Institute (NCI) | 3015 |
| University of Arizona | 138 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| British Columbia Cancer Agency | Vancouver | Canada | 7 |
| Dalhousie University | Halifax | Canada | 5 |
| Emory University Hospital/Winship Cancer Institute | Atlanta | United States | 299 |
| Louisiana State University | Lafayette | United States | 2 |
| Moffitt Cancer Center | Tampa | United States | 523 |
| NYU College of Dentistry | New York | United States | 3 |
| UC San Diego Medical Center - Hillcrest | San Diego | United States | 57 |
| University of Arizona Cancer Center-North Campus | Tucson | United States | 126 |
| University of Michigan Comprehensive Cancer Center | Ann Arbor | United States | 88 |
| University of Minnesota/Masonic Cancer Center | Minneapolis | United States | 105 |